
EHA 2026 highlights include advances in immunotherapy across blood cancers.

Julie Kanter, MD, is the codirector of the Lifespan Comprehensive Sickle Cell Center at the University of Alabama at Birmingham, where she is also a professor in the divisions of hematology and oncology.

EHA 2026 highlights include advances in immunotherapy across blood cancers.